Qlife Holding AB (OSTO:QLIFE) Gross-Profit-to-Asset % : 7.06% (As of Sep. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Qlife Holding AB Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Qlife Holding AB's annualized Gross Profit for the quarter that ended in Sep. 2023 was kr10.94 Mil. Qlife Holding AB's average Total Assets over the quarter that ended in Sep. 2023 was kr154.83 Mil. Therefore, Qlife Holding AB's annualized Gross-Profit-to-Asset % for the quarter that ended in Sep. 2023 was 7.06%.

Qlife Holding AB Gross-Profit-to-Asset % Historical Data

The historical data trend for Qlife Holding AB's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qlife Holding AB Gross-Profit-to-Asset % Chart

Qlife Holding AB Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Gross-Profit-to-Asset %

43.58

15.10

-6.03

Qlife Holding AB Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Gross-Profit-to-Asset %	Get a 7-Day Free Trial														25.80	-97.75	13.04	9.70	7.06

Competitive Comparison of Qlife Holding AB's Gross-Profit-to-Asset %

For the Medical Devices subindustry, Qlife Holding AB's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Qlife Holding AB's Gross-Profit-to-Asset % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Qlife Holding AB's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Qlife Holding AB's Gross-Profit-to-Asset % falls into.

Qlife Holding AB Gross-Profit-to-Asset % Calculation

Qlife Holding AB's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2022 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: Dec. 2022 )	/	( (Total Assets (A: Dec. 2021 )	+	Total Assets (A: Dec. 2022 ))	/ count )
	=	-10.749	/	( (164.001	+	192.65)	/ 2 )
	=	-10.749	/	178.3255
	=	-6.03 %

Qlife Holding AB's annualized Gross-Profit-to-Asset % for the quarter that ended in Sep. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: Sep. 2023 )	/	( (Total Assets (Q: Jun. 2023 )	+	Total Assets (Q: Sep. 2023 ))	/ count )
	=	10.936	/	( (159.642	+	150.009)	/ 2 )
	=	10.936	/	154.8255
	=	7.06 %

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Sep. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Qlife Holding AB Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Qlife Holding AB's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

Qlife Holding AB (OSTO:QLIFE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Qlife Holding AB (OSTO:QLIFE) » Definitions » Gross-Profit-to-Asset %

Comparable Companies

Traded in Other Exchanges

4HG:Germany

Address

Redaregatan 48, Helsingborg, SWE, SE-252 36

Website

https://www.qlifeholding.com

Qlife Holding AB is a medical device company that seeks to revolutionize the clinical biomarker testing of whole blood by taking it out of the lab and into the homes of the people who needs it. The Egoo Home System is an integrated platform consisting of a small home device and disposable capsules, each of which tests for a specific biomarker. It provides a digital infrastructure for sharing the data with the patient's doctor, clinic or hospital via smartphone and computer.

Qlife Holding AB (OSTO:QLIFE) Headlines

No Headlines